IVITF - Invictus MD Strategies Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
0.2972
-0.0061 (-2.01%)
At close: 3:42PM EDT
Stock chart is not supported by your current browser
Previous Close0.3033
Open0.3095
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.2972 - 0.3130
52 Week Range0.2750 - 1.8100
Volume21,937
Avg. Volume200,842
Market Cap36.491M
Beta (3Y Monthly)3.40
PE Ratio (TTM)N/A
EPS (TTM)-0.1410
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend Date2016-11-17
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire6 days ago

    Invictus announces Annual General Meeting Date

    Vancouver, British Columbia, June 20, 2019 -- Vancouver, BC, June 20, 2019 – INVICTUS MD STRATEGIES CORP. (“Invictus” or the “Company”) (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2).

  • GlobeNewswire14 days ago

    UPDATE ON ACREAGE PHARMS LTD.

    Vancouver, British Columbia, June 12, 2019 -- INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) Mr. Trevor Dixon, Chief Executive.

  • GlobeNewswire15 days ago

    INVICTUS ANNOUNCES APPOINTMENT TO BOARD

    FRA: 8IS2) announced today that Mr. Colin Kinsley has been appointed to the Board of Directors as an independent Director.  Mr. Kinsley previously served on the Board of Directors of the Corporation (the “Board”) from December, 2014 to June, 2017. Mr. Trevor Dixon, the Company’s Chief Executive Officer, said, “The Company is very pleased to have Mr. Kinsley join the Board.

  • GlobeNewswire21 days ago

    INVICTUS ANNOUNCES EXECUTIVE APPOINTMENT

    Vancouver, June 05, 2019 -- Vancouver, BC, June 5, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) announced today.

  • GlobeNewswire22 days ago

    INVICTUS ANNOUNCES CHANGES TO BOARD

    FRA: 8IS2) announced today that Mr. Richard Lee has been appointed to the Board of Directors as an independent Director.  Mr. Aaron Bowden has submitted his resignation as a Director in order to devote more time to his other business interests.  Mr. Bowden will continue to serve the Company as an advisor.  Mr. Bowden was appointed to the Board of Directors on August 19, 2016 and served as Chair of the Audit Committee.

  • OTC Markets Group Launches OTCQX Cannabis Index
    PR Newswire22 days ago

    OTC Markets Group Launches OTCQX Cannabis Index

    NEW YORK , June 4, 2019 /PRNewswire/ --  OTC Markets Group Inc.  (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the launch of the OTCQX® Cannabis Index ...

  • GlobeNewswire26 days ago

    INVICTUS ANNOUNCES CHANGE TO MANAGEMENT AND BOARD

    FRA: 8IS2) announces that the Board of Directors (the “Board”) has accepted Mr. George E. Kveton’s resignation as Chief Executive Officer (“CEO”) of the Company and Mr. Trevor Dixon, a member of the Board, will be assuming the role of CEO. “I am proud to be serving as the Company’s CEO,” said Mr. Dixon.  “I am committed to the long term and ongoing success of the Company as we work to improve production, increase revenue and decrease the cost of operations.

  • GlobeNewswirelast month

    Invictus Withdraws Plans for NASDAQ Listing and Related Share Consolidation

    FRA: 8IS2) announced today that the Company is withdrawing plans to list the Company’s common shares (the “Shares”) on NASDAQ Stock Market LLC (“NASDAQ”), as well as plans for the share consolidation that would have been required to meet NASDAQ’s minimum share price listing threshold. Plans for the NASDAQ listing and a share consolidation were originally announced in press releases dated January 17, 2019 and January 21, 2019.

  • PR Newswire2 months ago

    Invictus Announces Appointment of Director and Chief Operating Officer

    FRA: 8IS2) the Company is pleased to announce the appointment of Trevor Dixon as a Director and Chief Operating Officer of the Company effective immediately.  Mr. Dixon is the founder, President and Chief Executive Officer of the Company's wholly owned subsidiary Acreage Pharms Ltd. ("Acreage Pharms"). "Mr. Dixon brings 35 years of successful business experience to the leadership team of Invictus," said George E. Kveton, CEO of Invictus.

  • GlobeNewswire2 months ago

    INVICTUS GRANTS OPTIONS

    Vancouver, BC, April 26, 2019 -- INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) the Company has granted 200,000 incentive.

  • GlobeNewswire2 months ago

    Invictus To Develop CBD-Infused Sodas with Rock Icon Gene Simmons and Simmons’ Moneybag™ Sodas

    FRA: 8IS2) announced today that it has entered into a letter of intent (“LOI”) to form a Joint Venture (“JV”) with Gene Simmons (“Simmons”), Simmons’ MoneyBag Sodas (“MoneyBag™”) and  Rock Steady Sodas, Inc. (“Rock”) (each a “Party” and collectively the “Parties”) to develop a line of non-alcoholic, CBD-infused beverages for distribution in the United States and Canada. Rock will contribute expertise with existing premium soda recipes to be used with CBD and generations of bottling and distribution experience.

  • 5 Celebrities Making Money Off Pot Stocks
    InvestorPlace3 months ago

    5 Celebrities Making Money Off Pot Stocks

    Name your favorite celebrity? I bet they have a pot brand. Gone are the days of hawking wine and luxury goods to make an extra buck. The rise of cannabis has attracted movie stars, musicians, politicians, athletes, and people from many other backgrounds looking to put their stamp on the burgeoning industry. Many of the partnerships sprouting up between Hollywood and the cannabis industry are with publicly traded companies. As a result, some celebrities are getting wealthy off pot stocks. InvestorPlace - Stock Market News, Stock Advice & Trading TipsWho are they?Well, if you take a look at this list of 20 Celebrities Who Are Marijuana Enthusiasts, several are already involved in the cannabis industry. * 10 Medical Marijuana Stocks to Cure Your Portfolio I've taken some of the people on that list, added a few not mentioned, and created a list of five celebrities who could be in line for an outstanding payday should their pot stocks continue to move higher. Snoop Dogg, Canopy Growth (CGC)Source: Shutterstock When you think of celebrities and pot, Snoop would be on most people's list. The two go hand in hand. Snoop has been in a partnership with Canopy Growth (NYSE:CGC), Canada's largest cannabis company by market cap, since October 2016. Canopy's Tweed Shop online store is selling Snoop's Leafs by Snoop brand. To celebrate the occasion, Snoop threw a private party in Toronto for his new friends. Since then, Snoop's cannabis interests have taken off. In March 2018, Snoop's Casa Verde Capital raised $45 million in venture capital to invest in the cannabis industry. Recently, the musician connected his TV pal Martha Stewart with Canopy Growth CEO Bruce Linton. Stewart is working with the company to create a line of hemp-derived CBD pet products. "I think it's a starting spot that was comfortable for everyone involved. We have the science and she's a lifelong dog, horse, animal person," Linton said in early March. "This just seemed like a really balanced and suitable starting point."Snoop and Martha. Together again. Seth Rogen, Canopy Growth (CGC)Source: WikipediaThe Canopy Growth list of celebrity partners got a little longer March 29 when Canadian actor and comedian Seth Rogen and screenwriter Evan Goldberg announced a partnership with the company. The duo's brand is called Houseplant. After working together on the film Pineapple Express, Rogen and Goldberg created the Toronto-based company along with some other friends and colleagues. "We could not be more passionate about this company and are dedicated to doing everything the right way," stated Rogen. "It is extremely important to us to treat cannabis with the reverence it deserves. What a time!"Although no specific financial details were given, Canopy has acquired 25% of Houseplant, invested some working capital, and will provide the facilities to grow. For Canopy's part, it was careful to point out that its new partners aren't just figurehead, but actual business owners who've spent the past five years preparing to launch the company. * 5 Cannabis Stocks Set to Skyrocket -- According to Wall Street's Top Analysts Its first product is Houseplant Sativa. It will initially be sold in B.C., rolling out across Canada after that. Pre-rolled joints and softgels will follow later in 2019. All products will be grown and produced at Canopy's facilities in Smith's Falls, Ontario, where Canopy is based. Trailer Park Boys, Organigram (OGRMF)Source: Shutterstock I don't know how many Americans are familiar with the Trailer Park Boys: Ricky, Bubbles, and Julian. However, in Canada, their show ran on an off for close to 20 years. A crazy show that never was expected to go anywhere, the Trailer Park Boys have turned into a global following. It's for this reason that New Brunswick-based cannabis company OrganiGram (OTCMKTS:OGRMF) partnered with the Nova Scotia trio in November 2016 to produce Trailer Park Buds recreational pot at the company's facility in Moncton. "This relationship solidifies one of our strategic building blocks as we plan for the legalization of recreational use in Canada. The team at Trailer Park Boys have an aligned vision to develop a National brand with our assistance and we're incredibly excited at how the partnership will come to life," Ray Gracewood, Chief Commercial Officer at OrganiGram, said at the time. The interesting piece of this partnership is that the marketing rules surrounding recreational pot in Canada are so stringent, Trailer Park Buds almost didn't pass the sniff test. Under regulations, endorsements, sponsorships, testimonials aren't allowed. Neither are promotions appealing to youth or associating with a particular lifestyle. Luckily, almost two years of work didn't end up on the cutting room floor when recreational pot became legal last October. OtganiGram's Gracewood commented at the time of legalization that there was enough of a distance between the Trailer Park Boys and Trailer Park Buds to get the green light from Health Canada. That's excellent news for shareholders. Gene Simmons, Invictus MD Strategies (IVITF)Source: FlickrI wanna rock and roll all night and party every day. The words of Kiss' most successful song roll off the tongue keeping lead singer Gene Simmons in a very comfortable California lifestyle. A natural marketer and businessman, Simmons sensed Cannabis was going to be big and inserted himself into the industry by agreeing to become Invictus MD Strategies' (OTCMKTS:IVITF) chief evangelist in March 2018. "Three years ago, I was dismissive, arrogant and uninformed about medical cannabis and thought the whole notion of its medical uses as so much smoke and mirrors," Simmons said in July 2018. "But over the last few years, I've started to see the tremendous new information that scientists and researchers have been telling us about the incredible uses for this humble plant that just grows there in the ground. I'm incredibly bullish on the product and, particularly, on this company."Unfortunately, while Simmons was high on Invictus, investors don't appear to be high on Simmons or the company. Its stock is down 34% since Invictus and the Kiss frontman announced their relationship. * Critical Levels to Watch in 3 Marijuana Stocks However, Invictus paid him $2.5 million in cash, issued 2.6 million shares, with another four million shares to be issued in the future, so he's got $10 million reasons to get its stock price over $1. Tragically Hip, Hexo (HEXO)Source: Shutterstock The Tragically Hip is one of Canada's favorite bands. Its lead singer, Gord Downie, died of cancer at the age of 53 in October 2017. The band first partnered with Newstrike Brands (OTCMKTS:NWKRF) in May 2017 before Downie passed away. Not only did the members of the band invest in Newstrike, but they also agreed to partner with Newstrike in preparation of the legalization of cannabis in Canada. The band did its due diligence at the time and felt Newstrike had all the right ingredients from a scientific perspective to feel comfortable attaching the Tragically Hip name to the company. More than two years later, Quebec-based Hexo (NASDAQ:HEXO) swept in, agreeing to buy Newstrike for $260 million in HEXO stock. Each Newstrike shareholder will get 0.06332 of a HEXO share for every Newstrike share. Hexo acquired Newstrike in part because of the Tragically Hip but also because the company has a partnership with Toronto food company Neal Brothers to produce specialty edibles. That will be very popular with Canadians. Not sure how many shares the Tragically Hip have in Newstrike, but if I were them, I'd keep the HEXO shares they get in the takeover because Hexo's other deal with Molson Coors (NYSE:TAP) looks to be a good one. At the time of this writing Will Ashworth did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 9 Stocks That Would Be Hurt By a Mexico/U.S. Border Closure * 7 A-Rated Healthcare Stocks for Industry Expansion * 10 Stocks That Every 30-Year-Old Should Buy and Hold Forever Compare Brokers The post 5 Celebrities Making Money Off Pot Stocks appeared first on InvestorPlace.

  • GlobeNewswire3 months ago

    INVICTUS MAKES FIRST SHIPMENT TO ONTARIO CANNABIS STORE

    Vancouver, BC, April 01, 2019 -- INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) is pleased to have made its inaugural shipment.

  • GlobeNewswire3 months ago

    GENE SIMMONS TAKES INVICTUS ON TOUR

    Vancouver, BC, March 25, 2019 -- INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to report that the Company’s Chief.

  • GlobeNewswire3 months ago

    AB LABS AWARDED SALES LICENSE

    FRA: 8IS1) is pleased to announce that the Company’s licensed producer AB Labs Inc. (“AB Labs") has received a medical sales and processing license from Health Canada effective March 16, 2019, pursuant to the Cannabis Act and Cannabis Regulations (“CACR”). AB Labs, located in Hamilton, Ontario is at the heart of the Company’s presence in Eastern Canada, with its 16,000 square foot Phase 1 facility currently operating at full capacity, and its 40,000 square foot Phase 2 facility just weeks away from finalizing its Confirmation of Readiness submission to Health Canada.

  • GlobeNewswire3 months ago

    INVICTUS ANNOUNCES APPOINTMENT OF NEW CFO

    Vancouver, BC, March 15, 2019 -- INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce the appointment of.

  • GlobeNewswire4 months ago

    INVICTUS AND CANNAMERICA PROVIDE UPDATE ON HEMP AND CBD JOINT VENTURE

    FRA: 8IS1) is pleased to provide an update on its binding letter of intent to create a joint venture with Cannamerica Brands Corp. (CSE:CANA) (CNNXF) and CBDistribution Company Ltd. (collectively, the “Joint Venture”) that was previously announced on January 7, 2019, with the intention of acquiring hemp biomass for extraction into CBD isolate using purpose-built facilities for large scale CBD extraction. The transaction is anticipated to close on or before March 31, 2019. Each of the parties involved have received approval from their respective Board of Directors to enter into the Joint Venture.

  • GlobeNewswire4 months ago

    INVICTUS PROVIDES PROGRESS UPDATE ON LICENSED PRODUCER EXPANSION

    FRA: 8IS1) is pleased to provide an update on production and expansion plans at its Licensed Producers: Acreage Pharms Ltd. (“Acreage Pharms”), AB Laboratories Inc. (“AB Labs”) and 0989561 B.C. Ltd. ("Canandia"). Invictus is proud to have fulfilled 100 per cent of provincial product orders to date and looks to further strengthen its sales and distribution relationships with both public and private enterprises as the Company’s facilities reach full operating capacity. A production footprint of 189,000 square feet is underway, with more capacity to come online commensurate with market needs and funding.

  • These 3 Tiny Pot Stocks Are Diamonds in the Rough
    SmarterAnalyst4 months ago

    These 3 Tiny Pot Stocks Are Diamonds in the Rough

    Industry participants believe the cannabis segment will become a $500 billion industry.  For now, it is a fraction of that potential.  There have been some companies that have seen significant movements in their stock prices.  What I wanted to do is point out some lesser-known stocks that still have the potential for large movements in their stocks.  These stocks have lower volumes and are prone to bigger swings as these companies ramp up production.  If an investor could stomach a wild ride there may be long-term potential with these companies.1933 Industries1933 Industries (TGIFF) is a Canadian company whose market capitalization is just under $100 million. They are taking steps almost daily to grow their business including getting involved in Canadian adult-use cannabis sales.  Currently, the company operates in Nevada with retail and grow operations (although they have a presence in other states such as California and Colorado).  This company has potential as they are just on the cusp of profitability with their increasing revenue and their declining rate of net losses.  And, their stock is just starting to pick back up after its selloff from initial euphoria:If you want a detailed look at the company’s growth they have a large flow chart of their progression to date. I am still waiting to hear back from the company regarding their total production capabilities.  But, if you scan through the flow chart they provide my best guess is close to 50,000 kg of cannabis annually.  This puts the company at a potential valuation based on their production possibility and revenue potential.  I’m looking at a bigger picture with this company and think they have the ability to accelerate their earnings in short order.Invictus MDInvictus MD (IVITF) is about to up-list on the NASDAQ and that is good news for the stock.  The increased exposure on more mainstream markets will bring in higher volumes and tighter spreads reducing investor risk.  But, the real draw for me was the fact that within 18 months the company will be producing some 50,000 kg of cannabis annually.  With that kind of potential, this company could be nearly $1 billion valuation in about 20 months’ time as the company ramps up production.  However, the company’s current valuation is still below $100 million giving the potential of a 10-times price movement.Given these two variables, I like this company a great deal.  Also, their stock price is at a basic price of $0.74 per share allowing for ownership of large numbers.  I will be constantly monitoring the company as I look for new information on what is next for this company:AgraFloraFrom what I can tell, AgraFlora (PUFXF) is a perfect example of a company who’s stock is mis-priced.  First, the company has teamed up with a long-term tomato grower that has many years of experience with indoor growing facilities, HVAC, and controlled indoor grow environments for vegetables.  There is not a tremendous amount of difference in the grow process of one plant versus another.  So, the company’s partner may be the best yet in the industry.  AgraFlora will have 250,000 kg annual production facility up and running very shortly.  Plus, the partnership they have will ensure viability with getting their business up and running as they switch from tomatoes to cannabis.With 250,000 kg. of cannabis production capability, that could eventually value the company at $5 billion.  They are currently valued at under $100 million.  Their stock has been pushed downward but that may be a factor of the low volumes for the stock.  But, long-term, I see a tremendous amount of potential; this stock may become my favorite for a while:Check out the articles in this category focused on cannabis stocks. By gaining a strong foundation in both the fundamentals and technical details usually involved in cannabis stocks, you’ll be able to invest with greater confidence. Author’s Disclosure:  I have no positions on these stocks at this time nor will be placing trades on these stocks in the next 72 hours. More recent articles from Smarter Analyst: * Lyft (LYFT) Faces the Public; Should You Buy the Stock? * Is Microsoft (MSFT) Stock Still a Strong Pick for Growth? * This Undexpected Apple (AAPL) Announcement Justifies the Potential of Services Revenue * Think Twice Before You Buy Tesla (TSLA) Stock, Analyst Says

  • GlobeNewswire4 months ago

    INVICTUS PROVIDES UPDATE ON OIL EXTRACTION PROGRAM

    FRA: 8IS1) is pleased to announce that its wholly-owned subsidiary, Acreage Pharms Ltd. ("Acreage Pharms"), has successfully completed testing on two batches  of oil and is working to finalize its application to Health Canada to allow for the sale of bottled cannabis oil and cannabis resin. Acreage Pharms' closed-loop CO2 system performs Subcritical and Supercritical Fluid Extraction utilizing high-pressure carbon dioxide to extract essential oils from botanicals, using specific temperatures and pressures to withdraw different components from plants.

  • GlobeNewswire4 months ago

    INVICTUS SECURES SUPPLY AGREEMENT WITH THE ONTARIO CANNABIS RETAIL CORPORATION

    FRA: 8IS1) is pleased to announce that its wholly-owned subsidiary, Acreage Pharms Ltd. ("Acreage Pharms"), has signed an agreement to supply the Ontario Cannabis Retail Corporation (“OCRC”), through the Ontario Cannabis Store (“OCS”), with a selection of premium cannabis products for the adult recreational market. Acreage Pharms, located in Edson, Alberta, is Invictus’ largest purpose-built indoor facility fully licensed under the Cannabis Act and Cannabis Regulations.

  • GlobeNewswire4 months ago

    INVICTUS HIRES INTERIM CHIEF MARKETING OFFICER AND EXPANDS INVESTOR RELATIONS

    With over 35 years of branding experience in the healthcare sector, the Agency will leverage its expertise to help create, develop, and execute the go-to-market strategy for Invictus cannabis products. As interim CMO, the Agency will work with Authentic Brands Group (“ABG”) and Invictus’ senior leadership team to facilitate the anticipated launch of Invictus’ medical brand T2C, and adult recreational brands under Dukes and Sterling & Hunt.

  • Are Marijuana Stocks Generally Overvalued?
    InvestorPlace4 months ago

    Are Marijuana Stocks Generally Overvalued?

    The past several months have been incredible ones for marijuana stocks. Although many of them have been around for years, nationwide legalization in Canada and legalization progress in the United States has thrust a large handful of cannabis stocks like Canopy Growth (NYSE:CGC), Aurora Cannabis (NYSE:ACB) and Tilray (NASDAQ:TLRY) in the spotlight. It has also pushed most of these stocks much higher. Click to Enlarge Source: Shutterstock The sheer speed and scope prompts a huge question most investors have avoided asking, however -- are marijuana stock overvalued?They are.InvestorPlace - Stock Market News, Stock Advice & Trading TipsThere's more to the answer than just the acknowledgment though. Namely, being overvalued isn't the same thing as calling these companies a sham. It also doesn't preclude gains in the meantime that will make them even more overvalued, even beyond typical measures of value like price-to-earnings ratios or cash flow potential. It's not unfair to "value" this industry's players solely based on the premise for the time being.Nevertheless, at some point in time these organizations will have to justify their stunningly frothy prices. Once the market realizes they can't, that's when the wave of right-pricing begins. Experts Sound OffIt's undeniable that the pro-cannabis movement is gaining traction. Canada is completely on board, even if its retail choices are modest. Meanwhile, marijuana is now legal for one reason or another in ten U.S. states. The light at the end of the tunnel has set most marijuana stocks on fire, and for good reason. Not only does legalization represent more opportunity, it has made them potential acquisition targets. * 10 Stocks That Every 20-Year-Old Should Buy That doesn't mean investors have remained rational about the whole premise though.Consider something Canopy Growth CEO Bruce Linton said just late last week:"I think it's entirely true that cannabis has become frothy and I'm not saying that necessarily specifically about our [stock]. But you could list 85 or 90 names that are probably publicly listed that I as the operator of one of the first and most dominant [companies] have never heard of those companies."Again, that's from Bruce Linton, chief of Canopy Growth, and someone who has much to gain by not suggesting anything close to what he said.Linton isn't the only insider or industry expert to point out concern, however, that early pot investors have gotten ahead of themselves. Bethany Gomez, managing director at Brightfield Group, commented in a recent interview:"Another full third of consumers who are not purchasing through the retail market yet have cited pricing as one of their key concerns … that pricing differential between the recreational market and the black market … the market is really missing those mid to lower income cannabis consumers which are a significant portion of that population."In other words, a good-sized swath of would-be tokers -- and suppliers -- are still circumventing the legalized arm of the industry. Investors were pricing marijuana stocks as if the illegal side of the trade would shift to legal operations. One can't invest in the unregulated, illegal swath of the marijuana business that clearly still exists, and still competes with publicly traded outfits in the cannabis industry.Jon Najarian, co-founder of Investitute, was a little more blunt about the matter in September of last year, commenting on the wild runup of most marijuana stocks "This is just stupid time. I can't believe the valuations at this stage."Little has changed, valuation-wise, since then. All the Telltale SignsEven beyond the expert opinions though, the ancillary evidence of froth among these stocks is in place.No two bubbles are quite the same, but they all eventually sport the same core warning signs that are in place now. One of those warning signs in place now is, everyone and their uncle is talking about investing in marijuana … including people who've never actually invested a penny in their lives.And they're not just talking about it. They're adamant about it, to the point of being critical of those who are "missing out" on the movement. It's mostly an effort to assure themselves they made the right call.Another red flag? The industry's focus has shifted from doing the business to supporting those who want to get in the business to raising awareness -- and raising funds -- by merely name-dropping or leveraging celebrities' star power. Most notable among such moves is the naming of Gene Simmons, the face and lead singer of rock band Kiss, as the Chief Evangelist Officer of Invictus MD Strategies (OTCMKTS:IVITF). The company's Canadian ticker was even changed to 'GENE' to bolster the affiliation.It's a title fabricated solely for publicity purposes, with a role filled by a talented showman with no particularly related work experience.Lastly, the mindset keeping these names propped up, for the time being, is the same one that sent solar stocks soaring in 2008, oil stocks into a rocket-ride into 2014, gold in a frenzy in 2010 and 2011, bitcoin into a mania in 2017 and 3D printing stocks into high gear in 2012 and 2013. Those were all "must have" investments at the time, as they would change the world as we knew it. * 7 Forever Stocks to Buy for Long-Term Gains They didn't. The underlying stories sure were fun to think about though. Bottom Line for Marijuana StocksThe great irony (and frustration) is, cannabis is a real, viable industry. Some observers believe the global legal marijuana market could be worth nearly $150 billion by 2025. Even half of that figure would still be an incredible opportunity.It's short-sighted, however, to believe the market's most-talked-about marijuana stocks are going to hold onto their present prices between now and then. Much can happen within the next five years that sheds the light of reality on these hyped-up names, not the least of which is the plethora of privately held companies that could end up outgrowing outfits like Tilray and Canopy Growth by avoiding all the trappings of being publicly traded entities.It certainly doesn't mean certain cannabis stocks won't see more short-term forward progress again, in the near or distant future. A bubble has made marijuana stocks sharply overvalued in terms of risk, potential and how compelling their stories are though … even if few want to admit it.As of this writing, James Brumley did not hold a position in any of the aforementioned securities. You can learn more about James at his site, jamesbrumley.com, or follow him on Twitter, at @jbrumley. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Fundamentally Sound Dividend Stocks to Buy * 5 Reasons Reeling FAANG Stocks Won't Deliver Big Returns * 3 Reasons Canopy Growth Could Burn You Compare Brokers The post Are Marijuana Stocks Generally Overvalued? appeared first on InvestorPlace.

  • GlobeNewswire5 months ago

    CBD Gummies In High Demand; International Spirits and Beverage Group (OTC: ISBG), Invictus MD Strategies, CV Sciences and Canopy Growth

    Investorideas.com, a leading investor news resource covering hemp and cannabis stocks, releases a snapshot focused on the CBD edibles market and how, specifically, CBD gummies are in high demand. Building on that, Transparency Market Research expects the global market for gummy vitamins to rise at a steady CAGR of 5.2% during the period between 2017 and 2025. Last November, Canopy Growth Corporation (NYSE:CGC) (TSX:WEED.TO) started selling CBD-dominant softgels through its Tweed brand, containing 20 milligrams of CBD, and between 2.5 or 10 milligrams of THC.